Apyx Medical Corp (APYX)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Sales | 11,373 | 9,430 | 11,487 | 12,149 |
| Cost of sales | 4,290 | 3,765 | 4,533 | 4,656 |
| Gross profit | 7,083 | 5,665 | 6,954 | 7,493 |
| Salaries and related costs | - | - | - | 4,682 |
| Selling, general and administrative | 4,140 | 3,382 | 4,291 | 4,838 |
| Research and development | 824 | 804 | 1,142 | 1,424 |
| Professional services | 1,621 | 1,449 | 1,648 | 2,096 |
| Salaries and related costs | 3,072 | 3,081 | 3,508 | - |
| Total other costs and expenses | 9,657 | 8,716 | 10,589 | 13,040 |
| Loss from operations | -2,574 | -3,051 | -3,635 | -5,547 |
| Other (expense) income, net | - | - | - | -1 |
| Interest income | - | - | - | 439 |
| Interest expense | - | - | - | 1,427 |
| Other expense, net | - | - | 24 | -989 |
| Interest income | 278 | 304 | 378 | - |
| Interest expense | 1,393 | 1,376 | 1,431 | - |
| Total other expense, net | -1,115 | -1,072 | -1,029 | - |
| Loss before income taxes | -3,689 | -4,123 | -4,664 | -6,536 |
| Income tax expense | 49 | 49 | 60 | 50 |
| Net loss | -3,738 | -4,172 | -4,724 | -6,586 |
| Net income (loss) attributable to non-controlling interest | 40 | -22 | -21 | -30 |
| Net loss attributable to stockholders | -3,778 | -4,150 | -4,703 | -6,556 |
| Diluted eps | - | - | - | -0.19 |
| Diluted average shares | - | - | - | 34,644,000 |
| Basic and diluted (in dollars per share) | -0.09 | -0.1 | -0.14 | -0.19 |
| Weighted average shares outstanding - basic and diluted (in shares) | 40,729,000 | 40,729,000 | 34,644,000 | 34,644,000 |